Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

RMF van Schie; M Wadelius; F Kamali; AK Daly; VG Manolopoulos; A Boer; R Barallon; TI Verhoef; J Kirchheiner; M Haschke-Becher; M Briz; FR Rosendaal; Ken Redekop; M Pirmohamed; AH Maitland - van der Zee

doi:10.2217/pgs.09.125

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

RMF van Schie, M Wadelius, F Kamali, AK Daly, VG Manolopoulos, A Boer, R Barallon, TI Verhoef, J Kirchheiner, M Haschke-Becher, M Briz, FR Rosendaal, Ken Redekop, M Pirmohamed, AH Maitland - van der Zee

Epidemiology

Research output: Contribution to journal › Article › Academic › peer-review

128 Citations (Scopus)

72 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1287-1295
Number of pages	9
Journal	Pharmacoeconomics (Print)
Volume	10
Issue number	10
DOIs	https://doi.org/10.2217/pgs.09.125
Publication status	Published - 2009

Research programs

EMC NIHES-05-63-02 Quality

Access to Document

10.2217/pgs.09.125

19842940.pdfFinal published version, 451 KB

http://hdl.handle.net/1765/22600

Cite this

van Schie, RMF., Wadelius, M., Kamali, F., Daly, AK., Manolopoulos, VG., Boer, A., Barallon, R., Verhoef, TI., Kirchheiner, J., Haschke-Becher, M., Briz, M., Rosendaal, FR., Redekop, K., Pirmohamed, M., & Maitland - van der Zee, AH. (2009). Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacoeconomics (Print), 10(10), 1287-1295. https://doi.org/10.2217/pgs.09.125

@article{f46587948f984e97904be989563e7285,

title = "Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design",

author = "{van Schie}, RMF and M Wadelius and F Kamali and AK Daly and VG Manolopoulos and A Boer and R Barallon and TI Verhoef and J Kirchheiner and M Haschke-Becher and M Briz and FR Rosendaal and Ken Redekop and M Pirmohamed and {Maitland - van der Zee}, AH",

year = "2009",

doi = "10.2217/pgs.09.125",

language = "Undefined/Unknown",

volume = "10",

pages = "1287--1295",

journal = "Pharmacoeconomics (Print)",

issn = "1170-7690",

publisher = "Adis",

number = "10",

}

van Schie, RMF, Wadelius, M, Kamali, F, Daly, AK, Manolopoulos, VG, Boer, A, Barallon, R, Verhoef, TI, Kirchheiner, J, Haschke-Becher, M, Briz, M, Rosendaal, FR, Redekop, K, Pirmohamed, M & Maitland - van der Zee, AH 2009, 'Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design', Pharmacoeconomics (Print), vol. 10, no. 10, pp. 1287-1295. https://doi.org/10.2217/pgs.09.125

TY - JOUR

T1 - Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

AU - van Schie, RMF

AU - Wadelius, M

AU - Kamali, F

AU - Daly, AK

AU - Manolopoulos, VG

AU - Boer, A

AU - Barallon, R

AU - Verhoef, TI

AU - Kirchheiner, J

AU - Haschke-Becher, M

AU - Briz, M

AU - Rosendaal, FR

AU - Redekop, Ken

AU - Pirmohamed, M

AU - Maitland - van der Zee, AH

PY - 2009

Y1 - 2009

U2 - 10.2217/pgs.09.125

DO - 10.2217/pgs.09.125

M3 - Article

SN - 1170-7690

VL - 10

SP - 1287

EP - 1295

JO - Pharmacoeconomics (Print)

JF - Pharmacoeconomics (Print)

IS - 10

ER -